Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SNN - SMITH & NEPHEW PLC


26.19
0.100   0.382%

Share volume: 15,585
Last Updated: Wed 05 Feb 2025 07:30:05 PM CET
Surgical and Medical Instrument Manufacturing : -0.12%

PREVIOUS CLOSE
CHG
CHG%

$26.09
0.10
0.38%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
1.42%
1 Month
4.46%
3 Months
0.70%
6 Months
-12.57%
1 Year
-7.74%
2 Year
-9.11%
Key data
Stock price
$26.19
P/E Ratio 
51.28
DAY RANGE
$25.73 - $26.19
EPS 
N/A
52 WEEK RANGE
$23.65 - $31.72
52 WEEK CHANGE
-$8.69
MARKET CAP 
13.487 B
YIELD 
2.41%
SHARES OUTSTANDING 
437.175 M
DIVIDEND
$0.288
EX-DIVIDEND DATE
04/01/2024
NEXT EARNINGS DATE
N/A
BETA 
0.28
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$433,040
AVERAGE 30 VOLUME 
$787,571
Company detail
CEO: Deepak S. Nath
Region: US
Website: smith-nephew.com
Employees: 20,100
IPO year: 1999
Issue type: American Depository Receipt (ADR’s)
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Smith & Nephew plc develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products. It also provides sports medicine joint repair products for surgeons.

Recent news